Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu Liptovsky Mikulas
- Address
- lock Available on a paid plan
Nervous System Diseases
The Department of Psychiatry at Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu is conducting research focused on nervous system disorders, primarily exploring innovative treatments for migraine and immune‑mediated neuropathy.
- Acute migraine attack therapy
- Preventive migraine strategies
- Chronic Inflammatory Demyelinating Polyneuropathy management
- Evaluation of botulinum toxin for migraine reduction
With eight active studies and a team of seven investigators, the site in Liptovsky Mikulas, Slovakia aims to improve patient outcomes by testing new medications and assessing long‑term safety in real‑world settings.
Mental Disorders
In the realm of mental health, the same department is investigating novel adjunctive therapies for major depressive disorder, including patients with insomnia symptoms, to enhance the effectiveness of existing antidepressants.
- Adjunctive antidepressant treatment
- Depression with insomnia symptom management
- Long‑term safety of novel mood‑modulating agents
- Evaluation of new oral compounds for depressive symptoms
The research program, supported by the hospital’s clinical expertise, seeks to provide clearer treatment pathways for individuals living with major depressive disorder across Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Merz Therapeutics GmbH2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merz Therapeutics GmbH2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu Liptovsky Mikulas
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy of Azetukalner in Patients with Moderate-to-Severe Major Depressive Disorder | Xenon Pharmaceuticals Inc. | Phase III | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azetukalner | 2 | Unknown | 2026-02-26 | 2026-06-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.